BIIB Biogen Inc. - Fundamental Analysis
NEUTRAL
Sign in to save
Save to watchlist or track a position.
BIIB Stock | Fundamental Analysis & Investment Insights
NASDAQ
Healthcare
Drug Manufacturers - General
Current Price
Live
$171.59
Analyst Target
$192.14
+12.0%
Upside
52W High
$190.2
52W Low
$110.04
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
68%
Biogen's deterministic health score is weak with a Piotroski F-Score of 4/9, indicating borderline financial stability. While profitability metrics like gross margin (76.56%) and operating margin (30.72%) are strong, and the company trades below its Graham Number ($173.91) at $171.59, near-term earnings trends are concerning with YoY EPS down 22.3%. The lack of Altman Z-Score raises transparency concerns, but low debt (D/E: 0.36) and solid liquidity (Current Ratio: 2.72) support resilience. Analysts recommend a 'buy' with a $192.14 target, yet insider selling and weak technicals (10/100) counterbalance optimism.
Key Strengths
High gross margin (76.56%) reflecting pricing power and efficient manufacturing
Strong operating margin (30.72%) indicating effective cost control
Low debt-to-equity ratio (0.36) suggesting conservative capital structure
Current price ($171.59) near Graham Number ($173.91), implying defensive value
Analyst consensus recommendation is 'buy' with a 12.0% upside to target price
Key Risks
Weak Piotroski F-Score (4/9) signals potential financial instability
Missing Altman Z-Score limits ability to assess bankruptcy risk
Significant YoY and Q/Q EPS declines (-22.3%, -42.0%) despite recent earnings beats
Insider selling activity in last 6 months (1 sale, $0.07M) signals lack of confidence
Poor technical trend score (10/100) and weak long-term price performance (5Y: -37.7%)
AI Fair Value Estimate
Based on comprehensive analysis
$173.91
+1.4% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare BIIB against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning BIIB from our newsroom.
Newest → oldest
No matching news yet.